Nintedanib 150 mg capsules, Cipla

  • Product Name : Nintedanib 150 mg capsules, Cipla
  • Category : Anti Cancer
  • Manufacturer Name : Cipla
  • Trade Name : Cipla
  • Available Dosage : 150 MG
  • Packing : 30 Capsule
  • Pack Insert/Leaflet : 1 Pack (30 Capsule)
  • Ingredients : Nintedanib
  • Formulation : Capsule
  • Therapeutic use : Idiopathic pneumonic fibrosis
  • Production Capacity : 100000

Description:-

Introducing Nintib 150 Capsule: 


Advancing Treatment in Pulmonary Health Nintib 150 Capsule stands as a beacon of progress in the therapeutic landscape, specifically tailored for the treatment of idiopathic pulmonary fibrosis and non-small cell lung cancer. This powerful medication, when used judiciously, holds the potential to address these conditions effectively.


Optimizing Treatment with Nintib 150 Capsule:

For optimal results, Nintib 150 Capsule is recommended to be taken with food, ensuring a consistent daily intake to maximize benefits. Your healthcare provider, armed with specialized knowledge, will determine the necessary dosage and frequency, adapting as needed based on your specific condition. Precision in adhering to your doctor's guidance is imperative, as misinterpretation or excessive intake may result in severe side effects. While tangible benefits may take weeks or months to manifest, discontinuation should only occur under the explicit advice of your healthcare professional.


Key Applications of Nintib Capsule:


Idiopathic Pulmonary Fibrosis Treatment:

Nintib 150 Capsule takes center stage in the therapeutic approach to idiopathic pulmonary fibrosis, effectively curbing the growth of cancer cells and preventing their proliferation.


Non-Small Cell Lung Cancer Treatment:

Non-small cell lung cancer, affecting both smokers and non-smokers, encounters a formidable opponent in Nintib 150 Capsule. Whether used alone or in combination with other medications, this potent drug showcases its efficacy in addressing this significant type of lung cancer.


Advantages of Nintib 150 Capsule:


Idiopathic Pulmonary Fibrosis:

Idiopathic pulmonary fibrosis, characterized by thickening and stiffening of lung tissue, finds relief in Nintib 150 Capsule. By halting the growth of cancer cells and preventing their increase, this medication aims to alleviate symptoms such as shortness of breath and dry cough.


Non-Small Cell Lung Cancer:

Nintib 150 Capsule emerges as a crucial component in the treatment of non-small cell lung cancer. Recognized for its potency, it is essential for patients to discuss potential risks and benefits with their healthcare provider. During this treatment, it is advised to abstain from alcohol consumption, coupled with a commitment to staying adequately hydrated.


Unveiling the Mechanism of Action:

Nintib 150 Capsule operates as an anti-cancer medicine by blocking the abnormal protein's action that signals cancer cells to replicate. This strategic intervention effectively halts or slows the spread of cancer cells.